Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9016 |
High Similarity |
NPD3027 |
Phase 3 |
0.8525 |
High Similarity |
NPD2983 |
Phase 2 |
0.8525 |
High Similarity |
NPD2982 |
Phase 2 |
0.8522 |
High Similarity |
NPD228 |
Approved |
0.8443 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.84 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.8359 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8359 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8254 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.822 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.8211 |
Intermediate Similarity |
NPD3705 |
Approved |
0.8189 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8115 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7949 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7891 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7886 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7833 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7787 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7778 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7769 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7761 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7754 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7746 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7721 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7712 |
Intermediate Similarity |
NPD290 |
Approved |
0.7661 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7656 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7656 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7652 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7652 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7626 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7609 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7586 |
Intermediate Similarity |
NPD940 |
Approved |
0.7586 |
Intermediate Similarity |
NPD291 |
Approved |
0.7586 |
Intermediate Similarity |
NPD37 |
Approved |
0.7586 |
Intermediate Similarity |
NPD846 |
Approved |
0.7552 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7537 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7537 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7519 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7518 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1091 |
Approved |
0.75 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7482 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7481 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7464 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7463 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7448 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7447 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7432 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7432 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7432 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7417 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7407 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7398 |
Intermediate Similarity |
NPD821 |
Approved |
0.7383 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7357 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7328 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7315 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7313 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7297 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7295 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7295 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7295 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7293 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7279 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7279 |
Intermediate Similarity |
NPD5089 |
Approved |
0.726 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7234 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7217 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7209 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7192 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7192 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7181 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD1349 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1351 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1350 |
Approved |
0.7164 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7163 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7153 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7153 |
Intermediate Similarity |
NPD5297 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7132 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7132 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7132 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7132 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7132 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7122 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7122 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7122 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7121 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7113 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7113 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7109 |
Intermediate Similarity |
NPD1408 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7103 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7101 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7101 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7101 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7092 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7087 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7086 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7077 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7077 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7077 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7071 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7068 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7063 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7063 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7063 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD3179 |
Approved |
0.7059 |
Intermediate Similarity |
NPD3180 |
Approved |
0.7055 |
Intermediate Similarity |
NPD52 |
Approved |
0.7055 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7055 |
Intermediate Similarity |
NPD7526 |
Approved |
0.7055 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.7054 |
Intermediate Similarity |
NPD7534 |
Approved |
0.7054 |
Intermediate Similarity |
NPD7533 |
Approved |
0.705 |
Intermediate Similarity |
NPD1772 |
Clinical (unspecified phase) |
0.7049 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7049 |
Intermediate Similarity |
NPD968 |
Approved |
0.7042 |
Intermediate Similarity |
NPD7153 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7034 |
Intermediate Similarity |
NPD1774 |
Approved |
0.7032 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7029 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7023 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7016 |
Intermediate Similarity |
NPD556 |
Approved |
0.7016 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7014 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7014 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7007 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7 |
Intermediate Similarity |
NPD5691 |
Approved |
0.6992 |
Remote Similarity |
NPD3685 |
Discontinued |
0.6986 |
Remote Similarity |
NPD3157 |
Approved |
0.6986 |
Remote Similarity |
NPD3158 |
Phase 1 |
0.6985 |
Remote Similarity |
NPD596 |
Approved |
0.6985 |
Remote Similarity |
NPD600 |
Approved |
0.6978 |
Remote Similarity |
NPD447 |
Suspended |
0.6978 |
Remote Similarity |
NPD5735 |
Approved |
0.6968 |
Remote Similarity |
NPD4606 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6963 |
Remote Similarity |
NPD3691 |
Phase 2 |
0.6963 |
Remote Similarity |
NPD558 |
Phase 2 |
0.6963 |
Remote Similarity |
NPD6584 |
Phase 3 |
0.6963 |
Remote Similarity |
NPD3690 |
Phase 2 |
0.6962 |
Remote Similarity |
NPD7054 |
Approved |
0.6962 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6957 |
Remote Similarity |
NPD839 |
Approved |
0.6957 |
Remote Similarity |
NPD9365 |
Approved |
0.6957 |
Remote Similarity |
NPD840 |
Approved |
0.6954 |
Remote Similarity |
NPD5773 |
Approved |
0.6954 |
Remote Similarity |
NPD5772 |
Approved |
0.6954 |
Remote Similarity |
NPD4585 |
Approved |
0.695 |
Remote Similarity |
NPD5588 |
Approved |
0.695 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6947 |
Remote Similarity |
NPD9381 |
Approved |
0.6947 |
Remote Similarity |
NPD2667 |
Approved |
0.6947 |
Remote Similarity |
NPD2668 |
Approved |
0.6947 |
Remote Similarity |
NPD9384 |
Approved |
0.6944 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6934 |
Remote Similarity |
NPD7095 |
Approved |
0.6929 |
Remote Similarity |
NPD6653 |
Approved |
0.6929 |
Remote Similarity |
NPD1607 |
Approved |
0.6923 |
Remote Similarity |
NPD2933 |
Approved |
0.6923 |
Remote Similarity |
NPD2934 |
Approved |
0.6923 |
Remote Similarity |
NPD1432 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD6799 |
Approved |
0.6918 |
Remote Similarity |
NPD7472 |
Approved |
0.6918 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6917 |
Remote Similarity |
NPD1608 |
Approved |
0.6917 |
Remote Similarity |
NPD2235 |
Phase 2 |
0.6917 |
Remote Similarity |
NPD2231 |
Phase 2 |
0.6913 |
Remote Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD5353 |
Approved |
0.6908 |
Remote Similarity |
NPD2560 |
Approved |
0.6908
|
Remote Similarity |
NPD2563 |
Approved |